close

Products

1 132 133 134
Number of results: 2676
Date Compound Product name Company Disease Action mechanism Type of Information
2011-02-07 MOR103 MOR103 Morphosys (Germany) monoclonal antibody. MOR103 is a human monoclonal antibody to GM-CSF (granulocyte macrophage-colony stimulating factor). Granting of a patent
2010-10-01 16-base single-stranded peptide nucleic acid oligonucleotide linked to a 7-amino acid peptide 16-base single-stranded peptide nucleic acid oligonucleotide linked to a 7-amino acid peptide Biogenera (Italy)

medulloblastoma

antisens oligoucleotide.  16-Base single-stranded peptide nucleic acid oligonucleotide linked to a 7-amino acid peptide has been designed to block the gene coding… Granting of the orphan status in the EU
2007-11-29 human recombinant interferon-beta 1a Traumakine® - FP-1201 Faron Pharmaceuticals (Finland)

acute lung injury (ALI) acute respiratory distress syndrome (ARDS)

protein. FP-1201/Traumakine® is a human recombinant interferon-beta 1a. In acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), the predominant patho-physiological result… Granting of a patent
0201-06-01 aducanumab aducanumab (BIIB037) Biogen (USA - MA)

Alzheimer’s disease

monoclonal antibody. Aducanumab (BIIB037) is a human recombinant monoclonal antibody selected from a population of elderly, healthy donors and cognitively stable patients… Granting of a Fast Track status
0000-00-00 Plant acquisition
0000-00-00 Compound: Product name: sadasd dsadasdasd asdasdasdas Plant acquisition
0000-00-00 hj hjgh j vhv j Validation of a production plant
0000-00-00 Compound: bestttt asdasdasda asdasdasdas adsasdasdas Plant acquisition
0000-00-00 test test test test test Grant
0000-00-00 humanised IgG4 monoclonal antibody to the human toll-like receptor type 2 OPN-305 Opsona Therapeutics (Ireland) myelodysplastic syndromes monoclonal antibody. OPN-305 is a novel proprietary humanized IgG4 monoclonal antibody (MAb) against Toll-Like Receptor 2 (TLR2), a target within… Granting of the orphan status in the EU
0000-00-00 pppppppppp
0000-00-00
0000-00-00 Compound: bestttt vkh vki Action_mechanism: Company acquisition
0000-00-00 Compound: bestttt Laboratory Indication Action_mechanism:
0000-00-00 knjnlnlnln Product name:lknk nl nl lnl Licensing agreement
0000-00-00 test Establishment of a new subsidiary in the EU